Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney
- 1 October 2003
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 479 (1-3), 269-281
- https://doi.org/10.1016/j.ejphar.2003.08.076
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- PKC regulation of the human equilibrative nucleoside transporter, hENT1FEBS Letters, 2002
- CASE REPORT: Uric Acid Nephrolithiasis Associated with Interferon and Ribavirin Treatment of Hepatitis CDigestive Diseases and Sciences, 2001
- Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell lineBiochemistry and Cell Biology, 1998
- Na+-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cellsBiochemical Journal, 1998
- Gemcitabine—a safety reviewAnti-Cancer Drugs, 1998
- Cloning of the Human Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-insensitive Nucleoside Transporter ei by Functional Expression in a Transport-deficient Cell LinePublished by Elsevier ,1998
- Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cellsBiochemical Journal, 1996
- Primary Structure and Functional Expression of a cDNA Encoding the Bile Canalicular, Purine-specific Na+-Nucleoside CotransporterPublished by Elsevier ,1995
- Dideoxyinosine-associated nephrotoxicityAIDS, 1993
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991